Notable Labs Price to Book Ratio 2013-2024 | NTBLQ
Historical price to book ratio values for Notable Labs (NTBLQ) over the last 10 years. The current price to book ratio for Notable Labs as of October 24, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Notable Labs Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-10-22 |
0.25 |
|
0.33 |
| 2024-06-30 |
0.63 |
$0.74 |
0.84 |
| 2024-03-31 |
1.77 |
$1.28 |
1.38 |
| 2023-12-31 |
1.89 |
$1.68 |
1.13 |
| 2023-09-30 |
8.55 |
$8.27 |
1.03 |
| 2023-06-30 |
8.05 |
$9.54 |
0.84 |
| 2023-03-31 |
5.86 |
$9.98 |
0.59 |
| 2022-12-31 |
4.20 |
$-38.11 |
-0.11 |
| 2022-09-30 |
5.44 |
$12.69 |
0.43 |
| 2022-06-30 |
56.35 |
$17.33 |
3.25 |
| 2022-03-31 |
59.15 |
$21.58 |
2.74 |
| 2021-12-31 |
68.95 |
$25.74 |
2.68 |
| 2021-09-30 |
71.75 |
$27.79 |
2.58 |
| 2021-06-30 |
83.65 |
$30.89 |
2.71 |
| 2021-03-31 |
70.00 |
$22.87 |
3.06 |
| 2020-12-31 |
66.15 |
$22.43 |
2.95 |
| 2020-09-30 |
42.70 |
$27.14 |
1.57 |
| 2020-06-30 |
44.80 |
$31.05 |
1.44 |
| 2020-03-31 |
47.25 |
$30.22 |
1.56 |
| 2019-12-31 |
42.00 |
$35.10 |
1.20 |
| 2019-09-30 |
47.25 |
$40.10 |
1.18 |
| 2019-06-30 |
45.50 |
|
0.00 |
| 2019-03-31 |
53.20 |
|
0.00 |
| 2018-12-31 |
33.95 |
$51.74 |
0.66 |
| 2018-09-30 |
56.88 |
|
0.00 |
| 2018-06-30 |
77.00 |
|
0.00 |
| 2018-03-31 |
80.50 |
|
0.00 |
| 2017-12-31 |
248.50 |
$65.42 |
3.80 |
| 2017-09-30 |
213.50 |
|
0.00 |
| 2017-06-30 |
155.75 |
|
0.00 |
| 2017-03-31 |
192.50 |
|
0.00 |
| 2016-12-31 |
169.75 |
$55.11 |
3.08 |
| 2016-09-30 |
182.70 |
|
0.00 |
| 2016-06-30 |
161.35 |
|
0.00 |
| 2016-03-31 |
121.80 |
|
0.00 |
| 2015-12-31 |
184.10 |
$54.47 |
3.38 |
| 2015-09-30 |
261.80 |
|
0.00 |
| 2015-06-30 |
215.95 |
|
0.00 |
| 2015-03-31 |
182.00 |
|
0.00 |
| 2014-12-31 |
206.85 |
$61.68 |
3.35 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
